Investor FAQs
Where is the Biodesix corporate headquarters?
Our principal executive offices are located at 2970 Wilderness Place, Suite 100, Boulder, Colorado 80301, and our telephone number is (303) 417- 0500.
Where and when was Biodesix incorporated?
We were initially incorporated in Delaware in 2005 under the name Elston Technologies, Inc. We changed our name to Biodesix, Inc. in 2006.
When did Biodesix go public?
Biodesix went public on October 28, 2020.
On what stock exchange is Biodesix stock traded, and what is the ticker symbol?
Biodesix is traded on NASDAQ Exchange under the ticker symbol BDSX.
When does Biodesix’s fiscal year end?
Biodesix‘s fiscal year ends on December 31st.
How do I buy shares of Biodesix?
Shares of Biodesix can be purchased through a broker or stock purchase service of your preference.
Can I buy stock directly from Biodesix?
No, Biodesix does not have a direct stock purchase program.
Do you anticipate paying a dividend?
The company has not paid any dividends to its stockholders since its inception and does not plan to pay any cash dividends in the foreseeable future.
Who is Biodesix’s transfer agent, and how do I contact them?
The transfer agent and registrar for our common stock will be Computershare Trust Company, N.A. The transfer agent's address 150 Royall Street, Canton, Massachusetts 02021, and its telephone number is (800) 962- 4284.
Who are the Company’s independent registered public accountants?
Our independent registered public accountants are KPMG LLP.
Who is the Company’s external legal counsel?
Sidley Austin LLP serves as our external legal counsel.
Where can I find all of Biodesix’s SEC filings? Where can I download and view quarterly and annual reports?
Quarterly & Annual Reports and other investor materials are available under the SEC Filings page of the Investors section of the corporate website. Additionally, all SEC filings can also be accessed directly from the SEC website.
Where can I get the latest corporate news releases and financial reports?
You can view our latest press releases, including our quarterly financial releases, on the News Releases section of our website.
Whom should I contact regarding investor inquiries?